If you need more lookups,
subscriptions start at $34 USD/month.
Christine Location
San Diego, CA, US
Christine Work
Associate Director, Process Development @ (June 2022 - Present)
Principal Scientist, Process Development @ (January 2020 - June 2022)
Senior Scientist, Process Development @ (February 2019 - January 2020)
Senior Manager Technical Operations and QC @ SGI-DNA, A Synthetic Genomics Inc. Company (October 2017 - October 2018)
Senior Scientist II, Manager of Product Development @ (August 2014 - October 2017)
Research Scientist III @ (January 2007 - August 2014)
Research Scientist III, Stem Cell and Speciality Media @ (January 2012 - January 2014)
Research scientist III, Stem Cell @ (January 2009 - January 2012)
Research Scientist III, Cell Function and Analysis @ (January 2007 - January 2009)
Postdoc @ Scripps Research Institute (January 2002 - January 2007)
Christine Education
University of Massachusetts, Amherst 1997-2002
National Tsing Hua University 1993-1997
Christine Skills
Stem cell culture
CNS neural function
Medium development
Microscopy
Cell Biology
Assay Development
R&D
Stem Cells
Molecular Biology
Cell
Biotechnology
Cell Culture
GMP
Leadership
Oncology
Regenerative Medicine
Synthetic Biology
Troubleshooting
Communication
Biochemistry
Life Sciences
Laboratory
PCR
Data Analysis
Design of Experiments
Enzyme Assays
Protein Engineering
Mammalian Cell Culture
Stem Cell Research
Cell Based Assays
Molecular & Cellular Biology
DNA Sequencing
Christine Summary
Christine, based in San Diego, CA, US, is currently a Associate Director, Process Development at Fate Therapeutics Inc. Christine brings experience from previous roles at Fate Therapeutics Inc, SGI-DNA, A Synthetic Genomics Inc. Company and Synthetic Genomics. Christine holds a 1997 - 2002 University of Massachusetts, Amherst. With a robust skill set that includes Stem cell culture, CNS neural function, Medium development, Microscopy, Cell Biology and more. Christine has 2 emails on RocketReach.
Looking for a different Christine?
Find contact details for 700 million professionals.